Results

Total Results: 437 records

Showing results for "therapeutic".

61. Safe Medication Administration: Facilitator Guide | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/labor-delivery/perinatal-care/modules/strategies/medication/safe-medication-fac-guide.html
    July 01, 2023 - families regarding oxytocin use—for example, the infusion procedure, mobility restrictions, and expected therapeutic … Magnesium has a narrow therapeutic window requiring careful attention to appropriate administration. … Slide 21: Key Safety Elements: Standardize When Possible Say: When magnesium sulfate therapy … families regarding magnesium use—for example, the infusion procedure, mobility restrictions, and expected therapeutic

62. Final Progress Report: Clinical Prediction of Hepatotoxicity & Comparative Hepatic Safety of Medications (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/lo-report.pdf
    January 01, 2024 - additional evidence on the hepatic safety of medications, informing decision making about the appropriate treatments … Risk of acute liver injury with modern antiretroviral therapy (ART). … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis … Centers for Disease Control and Prevention: Therapeutic Drug Use. … Hepatotoxicity and antiretroviral therapy with protease inhibitors: A review.

63. Improving the Safety of Diagnosis and Therapy in the Inpatient Setting | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/resources/learning-lab/improving-safety-diagnosis-long-desc.html
    February 01, 2024 - Improving the Safety of Diagnosis and Therapy in the Inpatient Setting Principal Investigators … overall goal of this learning lab was to improve diagnostic safety and link diagnosis to the correct treatment … conduct: Problem analysis using systems engineering methods to analyze the problem of diagnostic and therapeutic … rapid, iterative prototyping of interventions to engage care teams and patients/caregivers to ensure treatment … Final Report: Improving the Safety of Diagnosis and Therapy in the Inpatient Setting.

64. Final Progress Report: Improving Patient Safety by Reducing Medication Errors (pdf file)
    www.ahrq.gov/sites/default/files/2024-03/strom2-report.pdf
    January 01, 2024 - government of the State of Pennsylvania and to the network of Centers for Education and Research in Therapeutics … These errors occur because of warfarin’s narrow therapeutic index. … Adherence with warfarin therapy is a paradigm for medical errors. … baseline as well as medication taking behaviors and physician practice variables throughout patients’ treatment … potentially important approaches to reducing errors associated with AABX as well as with other drug therapies

65. Medication Discrepancies and Potential Adverse Drug Events During Transfer of Care from Hospital to Home | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/reports/liability/neumiller.html
    August 01, 2017 - medication discrepancy in the transition from hospital to home care, and discrepancies occur within all therapeutic … Top Ten Therapeutic Drug Classes Resulting in Potential Adverse Drug Events (ADEs) Therapeutic … total medication discrepancies potentially resulting in an ADE, 425 (75 percent) involved these top 10 therapeutic

66. Safe Medication Administration: Magnesium Sulfate | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/labor-delivery/perinatal-care/modules/strategies/medication/tool-safe-mgso4.html
    July 01, 2023 - Complete removal of the line from the intravenous (IV) port when magnesium sulfate therapy is discontinued … Symptoms Magnesium Level (mg/dl) Normal adult values 1.7–2.4 Therapeutic range … Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or … PMID: 20177305. 7 WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. … Seizure prophylaxis or treatment in women with preeclampsia or eclampsia.

67. Addressing Today’s Steep Challenges of Providing High-Quality Behavioral Healthcare | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/blog/ahrqviews/high-quality-behavioral-healthcare.html
    December 01, 2022 - challenge clear, consistent, and simple measurement: the existing broad set of diagnoses, variable treatment … needs, trauma, physical disease, social drivers of health, and grief compound the presentation and treatment … Enormous variability exists in treatment models for behavioral health, ranging from pharmacotherapy and … While some evidence-based guidelines exist, there is often disagreement on the approach to treatment. … In addition, privacy standards and limited documentation impede the ability to categorize many therapeutic

68. Table 3. Evidence for Timely Bolus for Treatment of Children with Severe Sepsis of Septic Shock (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-5-table-3.pdf
    January 01, 2013 - Evidence for Timely Bolus for Treatment of Children with Severe Sepsis of Septic Shock Table 3: … Evidence for Timely Fluid Bolus for Treatment of Children with Severe Sepsis or Septic Shock Type … If the patient still shows signs of shock, additional therapy such as vasopressors should be administered … while diagnostic and therapeutic interventions are being performed. … outcomes for severe sepsis and septic shock: Tools for early identification of at-risk patients and treatment

69. AHRQ Safety Program for Perinatal Care: Safe Medication Administration (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.pdf
    May 01, 2017 - regarding oxytocin use—for example, the infusion procedure, mobility restrictions, and expected therapeutic … • Magnesium also has a narrow therapeutic window, requiring careful attention to appropriate administration … Administration 14 SAY: • When magnesium sulfate therapy is discontinued, remove the line from the … regarding magnesium use—for example, the infusion procedure, mobility restrictions, and expected therapeutic

70. Chapter 1 | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/resources/vision/resources/vision1.html
    October 01, 2002 - Rehabilitation services may include medical or surgical therapy, environmental measures, or social and … Services provided to target the disabling condition, including (1) medical/surgical treatment, (2) therapeutic … inpatient acute setting, (2) inpatient rehabilitative setting, skilled nursing facility, or outpatient therapeutic … Further, there is a lack of evidence regarding the association between therapeutic intensity (measured … absence of clearly superior alternatives, choices must be made between therapies without proven superiority

71. State Variation in Opioid Prescription Fills After Childbirth Among Women Ages 18-44 With Commercial Insurance (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-stat-brief-2-postpartum-opioid-rx.pdf
    March 01, 2024 - Postpartum Opioid Prescription Fills, Opioid Use Disorder, and Utilization of Medication-Assisted Treatment … aspe.hhs.gov/reports/postpartum-opioid-prescription-fills-opioid-use-disorder-utilization-medication-assisted-treatment … analysis include respiratory agents, antitussives, and drugs commonly used in medication-assisted treatment … synthetic generic drug names in SyH-DR, where the synthetic generic drug names belonged to the same therapeutic … In other words, the drug names in SyH-DR preserve the therapeutic classes observed in a claim in the

72. Nursing Home Resources | Agency for Healthcare Research and Quality
    www.ahrq.gov/nursing-home/resources/search.html?page=12
    January 01, 2022 - Therapeutic Options To Prevent Severe COVID-19 in Immunocompromised People During this webinar, presenters

73. Overuse of Computed Tomography Scans for the Evaluation of Children with Atraumatic Headache: Technical Specifications (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0206-technicalspecs.pdf
    May 01, 2016 - CODE SPINAL TAP Spinal puncture lumbar diagnostic 62270 Spinal tap 03.31 Anesthesia for dx or therapeutic … intracranial nerve 00222 Stereotactic placement of infusion catheter(s) in the brain for delivery of therapeutic … agent(s), including computerized stereotactic planning and burr hole(s) 0169T Anesthesia for therapeutic … procedures involving the arterial system; intracranial, intracardiac, or aortic 01926 Anesthesia for therapeutic … ventricular catheter/reservoir; with injection of medication or other substance for diagnosis or treatment

74. Primary Care-Integrated Long COVID Care to Improve Outcomes for Minoritized Adults in New York City (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/coronavirus/long-covid-care-network/mt-sinai-grantee-profile.pdf
    February 01, 2024 - underserved communities but also reduce wait times and provide a platform for testing innovative Long COVID treatment … the Mount Sinai team on shared care planning and shared decision making, in order to foster a trusted therapeutic

75. Pain Management Injection Therapies for Low-back Pain: Topic Refinement (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/lbpinject-topicref.pdf
    March 03, 2014 - Broadly, these can be classified as pharmacological treatments,15 non-pharmacological treatments (e.g … ., exercise therapy, cognitive behavioral therapy, spinal manipulation, acupuncture, and others),16 … injection therapies,17 and surgical treatments.18 Injection therapies, the topic of this evidence review … Ablative therapies include radiofrequency denervation, intradiscalelectrothermal therapy, percutaneous … Effectiveness of therapeutic lumbar transforaminal epidural steroid injections in managing lumbar spinal

76. Variation in the Implementation of California's Full-Service Partnerships | Agency for Healthcare Research and Quality
    www.ahrq.gov/practiceimprovement/delivery-initiative/gilmerstudysnapshot/index.html
    April 01, 2015 - Health Services Act (MHSA), full-service partnerships (FSPs) provide integrated, supported housing and treatment … have housing readiness requirements (such as mandatory time spent in transitional housing or requiring treatment … participation requirements for services (63 percent), pharmacotherapy (67 percent), or substance use treatment … equals with valid, authoritative views; prioritize income and housing over medication; understand the therapeutic

77. Nursing Home Resources | Agency for Healthcare Research and Quality
    www.ahrq.gov/es/nursing-home/resources/search.html?page=12
    January 01, 2022 - Therapeutic Options To Prevent Severe COVID-19 in Immunocompromised People During this webinar, presenters

78. Appendix B: Risk Assessment Models, Protocols, and Order Sets | Agency for Healthcare Research and Quality
    www.ahrq.gov/es/patient-safety/settings/hospital/vtguide/appb.html
    October 01, 2022 - . |___| No Prophylaxis, Ambulate: Patient is at risk for VTE but on therapeutic anticoagulation. |_ … mobility or If any VTE risk factor present VTE risk factors 1 Active cancer or cancer treatment … Use of hormone replacement therapy. Use of oestrogen-containing contraceptive therapy. … compression device OR Contraindication to pharmacologic prophylaxis, including already on therapeutic … Active cancer/cancer therapy with expected LOS >48 hours.

79. Appendix B: Risk Assessment Models, Protocols, and Order Sets | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/hospital/vtguide/appb.html
    October 01, 2022 - . |___| No Prophylaxis, Ambulate: Patient is at risk for VTE but on therapeutic anticoagulation. |_ … mobility or If any VTE risk factor present VTE risk factors 1 Active cancer or cancer treatment … Use of hormone replacement therapy. Use of oestrogen-containing contraceptive therapy. … compression device OR Contraindication to pharmacologic prophylaxis, including already on therapeutic … Active cancer/cancer therapy with expected LOS >48 hours.

80. Sample Scenario for Antepartum Hemorrhage In Situ Simulation | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/labor-delivery/perinatal-care/modules/situ/simulation-antepart-hemorrhage.html
    July 01, 2023 - the team to experience the normal passage of time required to order and access necessary supplies for treatment … The facilitator should allow the patient to have pain and bleeding despite any and all diagnostic or therapeutic … The facilitator should allow patient to continue bleeding despite any and all diagnostic or therapeutic